Q2 2021 Holdings
Filed 2021-08-16 | 46 holdings | $915.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | Sponsored ADR | 04016X101 | $285.0M | 946,500 | 31.1% |
| Ascendis Pharma(ASND) | Sponsored ADR | 04351P101 | $249.9M | 1,900,000 | 27.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | Common | 02043Q107 | $169.5M | 1,000,000 | 18.5% |
| Biomarin Pharmaceutical Inc(BMRN) | Common | 09061G101 | $137.7M | 1,650,000 | 15.0% |
| Acadia Pharmaceuticals Inc(ACAD) | Common | 004225108 | $59.6M | 2,441,658 | 6.5% |
| Adaptimmune Therapeutics PLC(ADAPY) | Sponsored ADR | 00653A107 | $8.6M | 2,024,400 | 0.9% |
| Horizon Therapeutics PLC | Common | G46188101 | $842.8K | 9,000,000 | 0.1% |
| Mirati Therapeutics Inc(MRTXEUR) | Common | 60468T105 | $807.7K | 5,000,000 | 0.1% |
| United Therapeutics Corp(UTHR) | Common | 91307C102 | $538.2K | 3,000,000 | 0.1% |
| Acceleron Pharma Inc(XLRN) | Common | 00434H108 | $376.5K | 3,000,000 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | Common | 040047607 | $277.9K | 4,075,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | Common | 462260100 | $236.8K | 9,100,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | Common | 803607100 | $186.6K | 2,400,000 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | Common | 92532F100 | $159.3K | 790,000 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | Common | 558868105 | $138.8K | 1,425,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | Common | 03152W109 | $120.0K | 12,450,000 | 0.0% |
| Constellation Pharmaceuticals Inc(CNST) | Common | 210373106 | $108.5K | 3,210,000 | 0.0% |
| Mersana Therapeutics Inc | Common | 59045L106 | $92.3K | 6,800,000 | 0.0% |
| Kura Oncology Inc(KURA) | Common | 50127T109 | $86.3K | 4,140,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | Common | 98420N105 | $68.0K | 3,650,000 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | Common | 03753U106 | $63.5K | 1,005,230 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | Common | 69353Y103 | $62.3K | 1,825,000 | 0.0% |
| Monte Rosa Therapeutics Inc(GLUE) | Common | 61225M102 | $62.2K | 3,311,434 | 0.0% |
| Marinus Pharmaceuticals Inc(MRNS*) | Common | 56854Q200 | $58.0K | 3,235,000 | 0.0% |
| Trillium Therapeutics Inc | Common | 89620X506 | $55.3K | 5,700,000 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | Common | 87164F105 | $51.5K | 3,000,000 | 0.0% |
| Mannkind Corp(MNKD) | Common | 56400P706 | $47.0K | 8,630,000 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | Common | 23257D103 | $44.9K | 10,300,000 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | Common | 46583P102 | $40.5K | 6,425,000 | 0.0% |
| Deciphera Pharmaceuticals Inc(DCPHEUR) | Common | 24344T101 | $39.1K | 1,068,000 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | Common | 75955J402 | $29.9K | 935,000 | 0.0% |
| Avadel Pharmaceuticals PLC | Sponsored ADR | 05337M104 | $29.4K | 4,365,000 | 0.0% |
| Praxis Precision Medicines Inc | Common | 74006W108 | $29.2K | 1,600,000 | 0.0% |
| Design Therapeutics Inc(DSGN) | Common | 25056L103 | $26.4K | 1,468,318 | 0.0% |
| Amarin Corp PLC | Sponsored ADR | 023111206 | $26.3K | 6,000,000 | 0.0% |
| Olema Pharmaceuticals Inc(OLMA) | Common | 68062P106 | $24.5K | 876,986 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | Common | 00773U108 | $24.3K | 6,950,000 | 0.0% |
| Merus N V | Common | N5749R100 | $13.9K | 660,000 | 0.0% |
| Avidity Biosciences Inc(RNA) | Common | 05370A108 | $13.5K | 545,000 | 0.0% |
| Fennec Pharmaceuticals Inc(FENC) | Common | 31447P100 | $12.2K | 1,670,000 | 0.0% |
| Genocea Biosciences Inc(GNCAQ) | Common | 372427401 | $11.9K | 5,084,184 | 0.0% |
| Centessa Pharmaceuticals PLC(CNTA) | Sponsored ADS | 152309100 | $11.1K | 500,000 | 0.0% |
| Bctg Acquisition Corp | Common | 05492W103 | $9.1K | 800,000 | 0.0% |
| Aerpio Pharmaceuticals Inc | Common | 00810B105 | $7.6K | 4,500,000 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS)Call | Common | 03753U106 | $3.4K | 240,000 | 0.0% |
| Alnylam Pharmaceuticals Inc(ALNY)Call | Common | 02043Q107 | $1.4K | 150,000 | 0.0% |